Reduced Dose Radiotherapy for the Treatment of Indolent Non-Hodgkin Lymphoma

Clinical trial NCT06386315 · RECRUITING

Trial details

NCT number: NCT06386315
Sponsor: Mayo Clinic
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Indolent B-Cell Non-Hodgkin Lymphoma Recurrent Indolent B-Cell Non-Hodgkin Lymphoma Refractory Indolent B-Cell Non-Hodgkin Lymphoma Recurrent Indolent Non-Hodgkin Lymphoma Refractory Indolent Non-Hodgkin Lymphoma

Start date: 2024-05-15
Primary completion: 2027-05-30
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.